Karius
2014
FOUNDED
PRIVATE
STATUS
Series B
LATEST DEAL TYPE
$165M
LATEST DEAL AMOUNT
13
INVESTORS
Description
Provider of high-complexity clinical laboratory testing intended for generating genomic insights for infectious diseases. The company platform map each patient's microbial landscape from a single blood draw and develops molecular biology and data analysis tool that uses deep sequencing to detect minuscule traces of microbial DNA directly from blood, enabling clinicians, molecular biologists, data scientists, software engineers, and commercial experts to make rapid and life-saving treatment decisions.
Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Other Pharmaceuticals and Biotechnology
Primary Office
- 975 Island Drive
- Suite 101
- Redwood City, CA 94065
- United States
+1 (866) 000-0000
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Karius’s full profile, request a free trial.
Karius Valuation and Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Later Stage VC (Series B) | 24-Feb-2020 | $165M | 00000 | Completed | Startup | |
| 4. Debt - General | 30-Nov-2018 | 0000 | 000.00 | Completed | Startup | |
| 3. Early Stage VC (Series A) | 07-Aug-2017 | 0000 | 000.00 | Completed | Startup | |
| 2. Accelerator/Incubator | $5.27M | Completed | Startup | |||
| 1. Seed Round | 20-Oct-2014 | $5.27M | $5.27M | 0000 | Completed | Startup |
Karius Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price |
% Owned |
|---|---|---|---|---|---|---|---|---|
| Series A | 00,000,000 | 00.000000 | 00.00 | 00.00 | 00.00 | 00 | 00.00 | 00.000 |
| Seed | 0,000,000 | 00.000000 | 00.00 | 00.00 | 00.00 | 00 | 00.00 | 00.00 |
Karius Competitors (10)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| IDbyDNA | Venture Capital-Backed | San Francisco, CA | 00 | 0000 | 00000000000 | 0000 |
| 000000 0000000000 | Venture Capital-Backed | Saint Louis, MO | 00 | 000.00 | 00000000000 | 000.00 |
| 0000000000 | Venture Capital-Backed | Abingdon, United Kingdom | 000 | 00000 | 00000000000 | 00000 |
| 00000 | Formerly PE-Backed | Thousand Oaks, CA | 00000 | 00.000 | 000000000000 | 00.000 |
| 0000 000000 | Formerly VC-backed | Santa Monica, CA | 000 | 00000 | 000000&0 | 00000 |
Karius Investors (13)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Board Seat |
Contact Info |
|---|---|---|---|---|---|---|
| General Catalyst | Venture Capital | Minority | 000 0000 | 000000 0 | ||
| HBM Healthcare Investments | Venture Capital | Minority | 000 0000 | 000000 0 | ||
| SoftBank Investment Advisers | PE/Buyout | Minority | 000 0000 | 000000 0 | ||
| aMoon Fund | Venture Capital | Minority | 000 0000 | 000000 0 | ||
| Casdin Capital | Hedge Fund | Minority | 000 0000 | 000000 0 |
Karius Executive Team (6)
2 Former Executives
You’re viewing 4 of 6 executives. Get the full list »Karius Board Members (5)
| Name | Representing | Role | Since | Contact Info |
|---|---|---|---|---|
| Mickey Kertesz Ph.D | Karius | Co-Founder, Chief Executive Officer & Board Member | 000 0000 | |
| Scott Barclay | Data Collective | Board Member | 000 0000 | |
| Tim Blauwkamp Ph.D | Karius | Co-Founder, Chief Scientific Officer & Board Member | 000 0000 |
2 Former Board Members
You’re viewing 3 of 5 board members. Get the full list »